Given the technical difficulties of the ELISA method, a gelatin particle agglutination test (MLPA) has been developed recently for the detection of anti-PGLI antibodies. The purpose of this study was to compare these 2 tests. MLPA was fo und to be less specific than ELISA (9 1% versus 98%, X2 = 66·8, p<O·OOI). The sensitivity of both tests was of 95% for the diagnosis of multi bacillary patients. In the case of paucibacillary patients. MLPA was fo und to be less sensitive than ELISA (21% versus 35%, X2 = 6'98, p>O·OI). The agreement between the 2 tests for a positive or a negative result was satisfying (85% to 100%), except for the weakly seropositive individuals (7 1 %). The correlation between OD obtained with ELISA and antibody titre obtained with MLPA was statistically significant (r = 0·70, p<O·OOl). Conversely to ELISA, MLPA was not applicable on blood samples absorbed on filter paper without a serious loss of sensitivity. In conclusion, this study demonstrated that the MLPA test can only reliably detect anti-PGLI antibodies in multibacillary cases.
MLPA tests for the diagnosis of leprosy, and secondly to define the applicability of the MLP A test on blood samples collected on filter paper.
Methodology

SERA TESTED
Negative controls
They were composed of 414 healthy Polynesian individuals without known contact with leprosy patients and 32 healthy persons from a nonendemic country.
Leprosy patients
We have tested the sera from 44 leprosy patients before treatment. According to the Ridley-Jopling scale they were classified as 21 multibacillary patients (4 BL, 17 LL) and 23 paucibacillary patients (7 1, '6 BT, 8 TT, 2 N).
Household contacts
A total of 262 household contacts were selected for this study. Using the ELISA method, 109 of them were seronegative and 153 were seropositive. These latter subjects were classified in 3 groups according to their antibody level: OD492 nm [0 , 200-0'300] for 66, [0· 300-0'600] for 66 and [> 0·600] for 21 of them.
The sequential sera from 6 contact's subjects who further developed leprosy (4 I, 1 BT, I LL) were also tested.
ANTI-PGLI ELISA TEST
The conventional indirect ELISA method for the detection of human IgM antibodies has been described in a previous study.IO The antigen used was the chemically synthesized trisaccharide NTP conjugated to bovine serum albumin kindly supplied by Dr T Fujiwara. I I The sera were screened at 1/250 dilution and the positives were semiquanti tated by two-fold dilutions. The threshold of ELISA test was 0·200 OD according to previous studies on Polynesian sera.1 2
PARTICLE AGGLUTINATION TEST MLPA
The MLPA kits in which the gelatin particles were sensitized with NTP antigen (Fujirebio Inc, Japan) were kindly supplied by the WHO Regional Office for the Western Pacific. The protocol of the test was according to the manufacturer's specification. A negative control was achieved with unsensitized gelatin particles at 1/16 final dilution of each serum. All the sera were screened with sensitized particles at 1/32 final dilution and a semi quantitative test using two-fold dilutions was conducted for the positive sera. The antibody titre was expressed as the highest dilution giving a positive pattern. The interpretation of the agglutination pattern was according to the manufacturer's criteria: negative (no agglutination or inconclusive agglutination), positive (complete agglutina-tion). Because of the subjective analysis on the degree of agglutination, the sera were coded.
M LP A on blood collected on Jilter paper
Blood obtained by pricking the finger-tip was absorbed on Whatman No. I paper cards with 5 mm diameter precut discs (Serobuvard, Laboratoire LDA, France).13 The processing of these samples was as fo llowed: fo ur paper discs per patient were eluted overnight into 100 microlitres of MLPA diluent, which is the minimum volume required to immerse the discs. According to the volume of blood absorbed on the filter, the final dilution of the sera for MLPA test was 1/25 for the control with unsensitized particles and 1/50 for the screening with sensitized particles.
STATISTICAL ANALYSIS
The agreement rate between MLPA and ELISA in detecting positive and negative subjects was calculated as fo llows: number of positive results + number of negative results by the 2 methods/total number sera tested x 100. The correlation between ELISA and MLPA was calculated according to the least square method and the X 2 method was used to compare percentages.
Results
SPECIFICITY FOR SERODIAGNOSIS OF LEPROSY
All of the 32 sera from healthy subjects living in nonendemic countries were negative both in ELISA and MLPA (100% of the agreement rate). The results of the 414 healthy Polynesian subjects are reported in Table 1 and the agreement rate for this group was 86%.
The specificity of MLPA and ELISA was 91·5% and 98%, respectively, when considering healthy Polynesian as negative controls (X 2 = 66·8, p < 0·00 I). 
SENSITIVITY FOR SERODIAGNOSIS OF LEPROSY
The results obtained in using the 2 tests on patients' sera are fo und in Table I . For the multi bacillary patients the agreement rate was 100% between the 2 tests and the sensitivity 95% for both tests. For the paucibacillary patients the agreement rate was 82% and sensitivity was 21% for MLPA and 35% for ELISA (X2 =6·98, P<0·01).
DETECTION OF ANTI-PGLI IN HOUSEHOLD CONTACTS
A total of262 selected contacts displaying a large range of antibody level were tested. The agreement rates between the 2 tests according to the different antibody level obtained by ELISA are reported in Table 2 . A significant correlation was obtained between the MLPA titres and the optical density obtained in ELISA (r = 0'70, p < 0'001).
The sequential sera from 6 contacts who developed leprosy (I LL, I BT, 4 I) could be tested by ELISA and MLPA. The results are reported in Table 3 . The agreement rate between MLPA and ELISA was 81 %.
APPLICABILITY OF MLPA FOR BLOOD SAMPLES COLLECTED ON FILTER PAPER
A total of 130 pairs of sera and blood absorbed on filter paper was tested with MLPA. Using the sera, 58 individuals (45%) were seronegative and 72 (55%) were seropositive. Using whole blood collected on Whatman paper, 109 (84%) were seronegative and 21 (16%) were seropositive. These latter individuals represented only 29% of the subjects fo und seropositive using the serum.
Discussion
The objectives of this study were to compare the gelatin particle agglutination test MLPA and the standard indirect ELISA test for the detection of anti-PGLI antibodies, and to evaluate the applicability of MLPA on blood samples collected on filter paper. For the serodiagnosis of leprosy patients, MLPA was fo und to be less specific than ELISA (/ = 66·8, p < 0,001). However, it is noteworthy that more than half of the fa lse positives using MLPA (15/27) that were negative in ELISA, had low antibody titre equal to 32. The positive pattern may be due to some biophysical peculiarities in some sera, that resulted in a non-specific agglutination of the particles. The sensitivity was 95% for both tests when considering the multi bacillary patients but for the paucibacillary patients, ELISA (35%) was more sensitive than MLPA (2 1 %) (X 2 = 6'98,p < 0'01). The paucibacill ary patients generally display a very low level of anti-PGLI antibodies that cannot be detected by MLPA. Anyhow, for these latter patients the PGLI is not a suitable antigen for serodiagnosis. The specificity ofMLPA can be improved to 96% ifits cut-off is fixed at 64 instead of32, but in that case the sensitivity for detecting the paucibacillary form of the disease drops to 4% as it remained at 95% for the multibacillary fo rm.
The agreement rate for positive or negative results between MLPA and ELISA was as good for patients as for contacts and ranged from 71 % to 100%. In general the concordance was the lowest for the individuals who were weakly positive in ELISA. The correlation between the MLPA titres and OD in ELISA was highly significant (r = 0'7, p < 0'001).
Because the agglutination test is rapid and easy to perform, it may constitute an interesting assay for large scale serological studies. Blood collected on filter paper has been used successfully in ELISA for the detection of anti-PGLI antibodies. 13 Tn this connection, we compared the results of MLPA obtained with the serum and with blood eluted from filter paper. The agreement rate obtained was fa ir (61 %) and only 29% of the positive individuals were fo und positive using filter paper. Because the titres were much lower when using blood absorbed on filter paper than when using serum obtained by venepuncture, the weakly positive subjects turned out to be negative. This may be explained by an inefficient elution of antibodies from the paper discs. This technical problem has proved difficult to overcome as, conversely to ELISA, a high concentration of sera is needed fo r MLPA and thus the volume of diluent used is too small to ensure a complete antibody elution. However, according to whether the prerogative of the test fo r a precise use is specificity or sensitivity, one can raise the cut-off, i.e. the screening dilution of the sera, and consequently use a larger volume of diluent for soaking the filter paper discs.
The usefulness of the detection of anti-PGLI has been extensively evaluated for the serodiagnosis of patients, the subclinical diagnosis among contact population, or the monitoring of patients during chemotherapy. The conclusions of these studies were that anti-PGLI assay can be used as an additional tool for the diagnosis of multibacillary patients, and also as an alternate tool to the BI determination for the surveillance of multi bacillary patients after treatment. In countries where the implementation of such a test is planned and where the technical facilities are too limited for setting up the ELISA method, the agglutination MLPA test may be a good substitute.
In conclusion, in spite of a lower specificity and sensitivity of MLPA for the detection of paucibacillary patients than ELISA, the agreement and the correlation between the 2 tests were satisfying. This study demonstrated that the MLPA test can only reliably detect the anti-PGLI antibodies in multibacillary patients and conversely to ELISA, MLPA was not applicable on blood absorbed on filter paper without a serious loss of sensitivity.
